Voronoi Co. Ltd.
Voronoi, Inc. researches, develops, and discovers small molecule kinase inhibitors in South Korea. Its products pipeline includes VRN01, an oral leucine rich repeat kinase 2 inhibitor targeting glioblastoma multiforme to treat brain and pancreatic cancers; VRN07, VRN06, and VRN11 for the treatment of lung cancer; VRN08 and VRN10 to treat breast cancer; and VRN02 for the treatment of rheumatoid ar… Read more
Voronoi Co. Ltd. (310210) - Total Assets
Latest total assets as of September 2025: ₩99.56 Billion KRW
Based on the latest financial reports, Voronoi Co. Ltd. (310210) holds total assets worth ₩99.56 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Voronoi Co. Ltd. - Total Assets Trend (2019–2024)
This chart illustrates how Voronoi Co. Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Voronoi Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Voronoi Co. Ltd.'s total assets of ₩99.56 Billion consist of 76.7% current assets and 23.4% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩10.15 Billion | 13.8% |
| Accounts Receivable | ₩80.78 Million | 0.1% |
| Inventory | ₩0.00 | 0.0% |
| Property, Plant & Equipment | ₩6.38 Billion | 8.7% |
| Intangible Assets | ₩1.03 Billion | 1.4% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Voronoi Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Voronoi Co. Ltd.'s current assets represent 76.7% of total assets in 2024, an increase from 5.5% in 2019.
- Cash Position: Cash and equivalents constituted 13.8% of total assets in 2024, up from 0.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 46.0% in 2019.
- Asset Diversification: The largest asset category is cash and equivalents at 13.8% of total assets.
Voronoi Co. Ltd. Competitors by Total Assets
Key competitors of Voronoi Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Voronoi Co. Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Voronoi Co. Ltd. generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Voronoi Co. Ltd. is currently not profitable relative to its asset base.
Voronoi Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 15.73 | 8.89 | 3.04 |
| Quick Ratio | 15.73 | 8.89 | 3.04 |
| Cash Ratio | 0.00 | 2.06 | 2.08 |
| Working Capital | ₩69.57 Billion | ₩ 57.76 Billion | ₩ 21.32 Billion |
Voronoi Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Voronoi Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 71.85 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -22.2% |
| Total Assets | ₩73.66 Billion |
| Market Capitalization | $2.46 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Voronoi Co. Ltd.'s assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Voronoi Co. Ltd.'s assets decreased by 22.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Voronoi Co. Ltd. (2019–2024)
The table below shows the annual total assets of Voronoi Co. Ltd. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩73.66 Billion | -22.18% |
| 2023-12-31 | ₩94.65 Billion | +48.01% |
| 2022-12-31 | ₩63.95 Billion | +59.24% |
| 2021-12-31 | ₩40.16 Billion | -15.82% |
| 2020-12-31 | ₩47.71 Billion | +55.97% |
| 2019-12-31 | ₩30.59 Billion | -- |